Interestingly, TGFβ1-treated organoids acquired a gene expression pattern representative of CMS4 suggesting that an atypical TGFβ1 response and a novel pEMT variant may underlie human CRC collective invasion. The gene discussed is TGFB1; the disease is colorectal carcinoma.